PMS2 Patient-Reported Outcomes in Rheumatoid Arthritis Patients Treated with Tofacitinib or Biological Dmards in Real Life Conditions: Colombian and Peru Perspective

Autor:	de Leon D Ponce, H. Madariaga, L. Amador, T. Lukic, Sanchez Jm Reyes, Ardila M Gutierrez
Rok vydání:	2021
Předmět:	medicine.medical_specialty Tofacitinib business.industry Health Policy Rheumatoid arthritis Perspective (graphical) Public Health Environmental and Occupational Health medicine In real life Intensive care medicine business medicine.disease
Zdroj:	Value in Health. 24:S138
ISSN:	1098-3015
DOI:	10.1016/j.jval.2021.04.679
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::fef1df058aa091cdda0d2ffd3d0fd1bd https://doi.org/10.1016/j.jval.2021.04.679 Zobrazit plný text záznamu Full Text from ScienceDirect